Inflammatory mediators are known to play a pivotal part in arthritis pathogenesis, characterized by chronic inflammation marked by increased pro‐inflammatory cytokine levels, including interleukin‐1β (IL‐1β) and tumor necrosis factor‐α [27]. Here, IL1B is linked to arthritic joint disease.